Word: burney
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...office last week after four years as surgeon general of the U.S. Public Health Service was Indiana's Dr. Leroy E. Burney, 54, an able administrator but ^ man who made no pretense of being a New Frontiersman. In Burney's office* sat Dr. Luther Leonidas Terry, 49, whose keener interest in research and in care for the aged make him more acceptable to the Kennedy Administration...
...While Burney put in a month as a special consultant to PHS, represented it at a W.H.O. conference in New Delhi (see FOREIGN NEWS...
...Public Health Service's Dr. Leroy E. Burney visited Kalaupapa last year to see whether the 95-year-old leprosy colony should be amalgamated with the only continental U.S. leprosarium, in Carville, La. Burney's conclusion: both should continue, for the time being. But Kalaupapa's life, at least as a leprosy settlement, appears limited. Hawaii has reported only 16 new cases of leprosy thus far this year (as compared to 94 in 1920), and less than half required hospitalization. Says Dr. Ira D. Hirschy. director of Hawaii's leprosy program: "As soon as the medical...
Before Dr. Burney's announcement, front runner among three U.S. groups seeking approval of a live-virus vaccine had been New York's Lederle Laboratories, using strains developed by Dr. Herald R. Cox. These have been put into a one-swallow, trivalent vaccine that 413,316 residents of Florida's Dade County (Miami and environs) took early this year. So far, there has been no case of paralytic polio in the county among the vaccinated, except seven which, say doctors, were already incubating when the victims took the vaccine...
...next summer, or fall at the latest, Americans will be able to take their polio vaccination in three month-apart swallows of live-virus vaccine instead of being dependent on the hypodermic needle for injections of the Salk killed-virus vaccine. Last week Surgeon General Leroy E. Burney of the U.S. Public Health Service said he had been convinced that it is now possible to manufacture a live-virus vaccine "suitable for use in the U.S." Whether this unexpectedly abrupt decision was the result of mounting evidence of safety or of pressure on the Government by live-virus advocates...